MelindaJElliottMD

Chief Medical Officer, Prolacta Bioscience

Dr. Elliott is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

I am an experienced, Board certified neonatologist who continues in practice with Pediatrix Medical Group. I am also the Chief Medical Officer for Prolacta Bioscience. I joined Prolacta after bringing an exclusively human milk diet to my very low birthweight patients and publishing the amazing results we achieved with better, all human milk based, nutrition. My interests focus on optimizing nutrition to newborn infants, particularly those born very prematurely or those requiring surgery in the neonatal period, while avoiding the risks of cow milk based nutrition.

Superstar Award Samuelson Children’s Hospital, 2012, 2016
Top Doc Baltimore Magazine, 2009, 2013-2015
Resident Teaching Award, Dept of Pediatrics Sinai Hospital, 2008, 2016
William Reichel Teaching Award 1997
Teaching Award American Academy of Family Physicians, 1993, 1995-1996, 1998, 2000-2002, 2004-2005, 2007
Pediatric Science Day, Honorable Mention 1985
Award for Scholarship in Medicine AMWA, 1984
Alpha Omega Alpha Medical Honor Society 1983
Passed comprehensive exams in Biology with Distinction Bethany College, 1980
Weimer Award in Biology Bethany College, 1980
Fellow American Academy of Pediatrics
Fellow (FAAP) American Academy of Pediatrics
Join now to see all

PubMed

Journal Articles

Alternative method of gestational age assessment by measurement of human erythrocyte differentiation antigen expression
Elliott MJ, Cassano WF, J Perinatol, 1/1/1991
Factors associated with age of onset of necrotizing enterocolitis
Convert RF, Neu J, Elliott MJ, Rea JL, Gimotty PA, Am J Perinatol, 1/1/1989

Abstracts/Posters

Factors Associated with Neonatal Respiratory Support in Infants with Meconium Stained Amniotic Fluid.
Elliott MJ. Hutchison AA, Conlon M, Williams JL, Cumming WA, Johnson JW, Clin Res, 1/1/1990
Quantitative assessment of gestational age by the measurement of human erythrocyte differentiation antigens.
Elliott M, Cassano W, Pediatr Res, 1/1/1990
The age of onset necrotizing enterocolitis is related to ventilation needs and feeding practices.
Covert RF, Neu J, Elliott MJ, Rea JL, Gimotty PA, Clin Res, 1/1/1988
Necrotizing enterocolitis may occur at late postnatal age with traditional risk factors.
Covert RF, Neu J, Elliott MJ, Rea JL, Pediatr Res, 1/1/1987
Join now to see all

Lectures

Decreased Incidence of NEC and Feeding Intolerance in Very Low Birth Weight Infants Receiving an Exclusive Human Milk Diet.
San Diego, CA - 1/1/2014
Implementing a Car Seat Testing Program in a Community Hospital Level III Neonatal Intensive Care Unit.
Baltimore, MD - 1/1/1995
Implementing a Neonatal Individualized Developmental Care and Assessment Program (NIDCAP) in a Community Hospital Neonatal Intensive Care Unit (NICU).
Orlando, FL - 1/1/1995
Factors associated with neonatal respiratory support in infants with meconium stained amniotic fluid.
New Orleans, LA - 1/1/1990
Quantitative assessment of gestational age using monoclonal antibodies to erythrocyte differentiation antigens.
Captiva Island, FL - 1/1/1989
The onset of necrotizing enterocolitis (NEC) is related to ventilation needs and feeding practices.
University of Florida, Gainesville, FL - 1/1/1987
Necrotizing enterocolitis (NEC) may occur without traditional risk factors and at late postnatal age.
1/1/1987
The age of onset of necrotizing enterocolitis is related to ventilation needs and feeding practices, abstracted.
1/1/1987
Terminal long arm deletion of chromosome 16.
1/1/1985
Join now to see all

Prolacta Bioscience Continues Advancing the Science of Human Milk, Proud to Partner with NICU Teams in Saving Lives of Premature InfantsSeptember 28th, 2021
Association of Women's Health, Obstetric, & Neonatal Nurses (AWHONN) Encourages an Exclusive Human Milk Diet (EHMD) for Vulnerable Preterm Infants in the Neonatal Intensive Care Unit (NICU)September 21st, 2021
Four Studies Showed Prolacta Bioscience's 100% Human Milk Based Fortifiers Reduced Retinopathy of Prematurity (ROP) in Premature InfantsMarch 17th, 2021
Join now to see all

Chief Medical Officer, Prolacta Bioscience2019 - Present
Senior Director, Clinical Education and Professional Development, Prolacta Bioscience2016 - 2019